Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 80


Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.

Pernas FG, Allen CT, Winters ME, Yan B, Friedman J, Dabir B, Saigal K, Mundinger GS, Xu X, Morris JC, Calvo KR, Van Waes C, Chen Z.

Clin Cancer Res. 2009 Apr 1;15(7):2361-72. doi: 10.1158/1078-0432.CCR-08-1011. Epub 2009 Mar 24.


A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.

Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT, Van Waes C, Chen Z.

Int J Cancer. 2008 May 1;122(9):1987-98. doi: 10.1002/ijc.23324.


Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer.

Friedman J, Nottingham L, Duggal P, Pernas FG, Yan B, Yang XP, Chen Z, Van Waes C.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6568-78.


A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status.

Lee TL, Yang XP, Yan B, Friedman J, Duggal P, Bagain L, Dong G, Yeh NT, Wang J, Zhou J, Elkahloun A, Van Waes C, Chen Z.

Clin Cancer Res. 2007 Oct 1;13(19):5680-91.


Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.

Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR.

Cancer Res. 2007 Jul 1;67(13):6520-7. Epub 2007 Jun 27.


Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma.

Allen C, Duffy S, Teknos T, Islam M, Chen Z, Albert PS, Wolf G, Van Waes C.

Clin Cancer Res. 2007 Jun 1;13(11):3182-90.


Getting connected: analysis and principles of biological networks.

Zhu X, Gerstein M, Snyder M.

Genes Dev. 2007 May 1;21(9):1010-24. Review.


Cancer systems biology: exploring cancer-associated genes on cellular networks.

Wang E, Lenferink A, O'Connor-McCourt M.

Cell Mol Life Sci. 2007 Jul;64(14):1752-62. Review.


Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.

Allen CT, Ricker JL, Chen Z, Van Waes C.

Head Neck. 2007 Oct;29(10):959-71. Review.


Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.

Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M.

Clin Cancer Res. 2007 Feb 15;13(4):1161-70.


Nuclear factor-kappaB in development, prevention, and therapy of cancer.

Van Waes C.

Clin Cancer Res. 2007 Feb 15;13(4):1076-82. Review.


Epithelial stem cells: turning over new leaves.

Blanpain C, Horsley V, Fuchs E.

Cell. 2007 Feb 9;128(3):445-58. Review.


Transcriptional profiling of the LPS induced NF-kappaB response in macrophages.

Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND.

BMC Immunol. 2007 Jan 12;8:1.


Clustering of genes into regulons using integrated modeling-COGRIM.

Chen G, Jensen ST, Stoeckert CJ Jr.

Genome Biol. 2007;8(1):R4.


Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.

Fanucchi MP, Fossella FV, Belt R, Natale R, Fidias P, Carbone DP, Govindan R, Raez LE, Robert F, Ribeiro M, Akerley W, Kelly K, Limentani SA, Crawford J, Reimers HJ, Axelrod R, Kashala O, Sheng S, Schiller JH.

J Clin Oncol. 2006 Nov 1;24(31):5025-33.


Regulation and function of IKK and IKK-related kinases.

H├Ącker H, Karin M.

Sci STKE. 2006 Oct 17;2006(357):re13. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk